Kwatra, SG, Yosipovitch, G, Legat, FJ, Reich, A, Paul, C, Simon, D, Naldi, L, Lynde, C, De Bruin-Weller, MS, Nahm, WK, Sauder, M, Gharib, R, Barbarot, S, Szepietowski, JC, Conrad, C, Fleischer, A, Laquer, VT, Misery, L, Serra-Baldrich, E, Lapeere, H, Ahmad, F, Lopez, ZKJ, Piketty, C, Ständer, S. Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(17)DOI:10.1056/NEJMoa2301333. PMID:37888917. IF:96.300(Q1/1D).

Rivera-Díaz R, Pozo T, Alfageme F, Díaz Ley B, Osorio GF, Chico R, Vilarrasa E, Silvente C, Ciudad Blanco C, Romaní J, Martorell A, Fernández P, Romero Ferreiro C, Molina Leyva A. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.. Actas Dermo-Sifiliograficas. 2023; 114(9)DOI:10.1016/j.ad.2023.06.018. PMID:37479135. IF:(Q/D).

Girolomoni, G, Savage, L, Gisondi, P, Svensson, A, Mahe, E, Augustin, M, Puig, L. Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review. Dermatology and Therapy. 2023; DOI:10.1007/s13555-023-01014. PMID:. IF:3.500(Q1/3D).

Gonzalez-Cantero, A, Boehncke, WH, De Sutter, J, Zamorano, JL, Lambert, J, Puig, L. Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Society of Dermatology and Venerology. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(9)DOI:10.1111/jdv.19191. PMID:37259959. IF:8.500(Q1/1D).

Berenguer-Ruiz S., Aparicio-Domínguez M., Herranz-Pinto P., Ruíz-Villaverde R., López-Ferrer A., Santos-Juanes J., Rodríguez Fernández-Freire L., Hospital-Gil M., Arias-Santiago S., Carretero-Hernández G., Mateu-Puchades A., Ferran M., del Alcázar E., Santos-Alarcón S., Garcia-Latasa de Aranibar F.J., Belinchón-Romero I., González-Cantero Á., Ruíz-Genao D., Eiris-Salvado N., Rocamora-Durán V., Rivera-Diaz R., de la Cueva P., Daudén E., Salgado-Boquete L., Llamas-Velasco M.. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19468. PMID:37625815. IF:8.500(Q1/1D).

Carmona-Rocha E., Aguado M., Tubau C., Sánchez S., Mozos A., Sullivan I., Spertino J.. Epidermolysis bullosa acquisita induced by atezolizumab. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023; DOI:10.1111/ddg.15203. PMID:37658659. IF:5.600(Q1/1D).

Carmona-Rocha, E, Puig, L. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy. 2023; 15(15)DOI:10.2217/imt-2023-0013. PMID:37609785. IF:2.700(Q3/7D).

Pereyra-Rodríguez J.J., Poveda J.L., Rivero A., Serra-Baldrich E., Silvestre J.F., Armario-Hita J.C., Calleja M.Á., Carrascosa J.M., Flórez Á., Herranz P., Comellas M., Ortiz de Frutos F.J.. Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19432. PMID:37594914. IF:8.500(Q1/1D).

Navarro-Compán V., Puig L., Vidal S., Ramírez J., Llamas-Velasco M., Fernández-Carballido C., Almodóvar R., Pinto J.A., Galíndez-Aguirregoikoa E., Zarco P., Joven B., Gratacós J., Juanola X., Blanco R., Arias-Santiago S., Sanz Sanz J., Queiro R., Canete, JD. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1191782. PMID:37600764. IF:5.700(Q1/3D).

Rusinol, L, Carmona-Rocha E., Puig L.. Psoriasis: a focus on upcoming oral formulations. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2023; 32(7)DOI:10.1080/13543784.2023.2242767. PMID:37507233. IF:4.900(Q1/2D).

Sahuquillo-Torralba A., Hospital-Gil M., Vilarrasa-Rull E., Llamas-Velasco M., Rivera R., Carrascosa J.M., de la Cueva-Dovao P., Armesto-Santos S., Ruíz-Villaverde R., Velasco-Pastor M., Magdaleno-Tapial J., Yanguas-Bayona J.I., Ribera-Pibernat M., Salgado-Boquete L., Herranz-Pinto P., Romero-Mate A., Martínez-Lorenzo E., López-Estebaranz J.L., Ballescá-López F., Botella-Estrada R.. Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2023; DOI:10.1111/ajd.14130. PMID:37435962. IF:2.200(Q2/5D).

Kirkham, BW, Egeberg, A, Behrens, F, Pinter, A, Merola, JF, Holzkaemper, T, Gallo, G, Ng, KJ, Bolce, R, Schuster, C, Nash, P, Puig, L. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis. Rheumatology and Therapy. 2023; 10(5)DOI:10.1007/s40744-023-00553-1. PMID:37400681. IF:2.900(Q2/4D).

Castellanos-Gonzalez, M, Bris, BB, Marsol, IB, Campos, MM, Ruiz-Villaverde, R, Llorente, CP, Nuno-Gonzalez, A, Sanchez, JT, Mur, EC, Garcia, RG, Alonso, AB, Espanol, GA, Garcia, YH, Schmidt, JMS, Sanchez, MA, Crespo, ER, Alonso, ED, Gallo-Pineda, G, Izquierdo, JAA, Varillas-Delgado, D. Pradiktive Faktoren fur Anti-MDA5-Antikorper bei Patienten mit Dermatomyositis: eine retrospektive multizentrische Studie. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023; 21(7)DOI:10.1111/ddg.15089_g. PMID:37427730. IF:5.600(Q1/1D).

Moreno-Arrones, OM, Bea-Ardebol, S, Mayo-Martinez, F, Perez-Pastor, G, Torres-Navarro, I, Bonfill-Orti, M, Deza, G, Ruiz-Salas, V, Masferrer, E, Feal, C, Turrion-Merino, L, Toll, A, Yebenes, M, Galiano-Mejias, S, Jaka, A, Ferrandiz-Pulido, C, Florez, A, Hernandez-Hernandez, N, Fernandez-de-Misa, R, Rios-Buceta, L, Sanmartin, O. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study. Actas Dermo-Sifiliograficas. 2023; 114(7)DOI:10.1016/j.ad.2023.06.011. PMID:37302483. IF:(Q/D).

Moreno-Arrones OM, Béa-Ardebol S, Mayo-Martinez F, Pérez-Pastor G, Torres-Navarro I, Bonfill-Ortí M, Deza G, Ruiz-Salas V, Masferrer E, Feal C, Turrión-Merino L, Toll A, Yébenes M, Galiano-Mejías S, Jaka A, Ferrandiz-Pulido C, Florez A, Hernández-Hernández N, Fernández-de-Misa R, Rios-Buceta L, Sanmartin O. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study.. Actas Dermo-Sifiliograficas. 2023; 114(7)DOI:10.1016/j.ad.2023.04.022. PMID:37088285. IF:(Q/D).

Longo C., Lippolis N., Lai M., Spadafora M., Kaleci S., Condorelli A.G., Lombardi M., Pampena R., Argenziano G., Nazzaro G., Scalvenzi M., Akay B.N., Broganelli P., Fargnoli M.C., Paoli J., Yélamos O., Pellacani G., Borsari S., Lallas A.. Dermoscopic features of trichoepithelioma: A multicentre observational case-control study conducted by the International Dermoscopy Society. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19262. PMID:37326166. IF:8.500(Q1/1D).

Costanzo A., Llamas-Velasco M., Fabbrocini G., Cuccia A., Rivera-Diaz R., Du Jardin, KG, Kasujee I., Puig L., Carrascosa J.M.. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19229. PMID:37246505. IF:8.500(Q1/1D).

Zabotti, A, De Marco, G, Gosset, L, Baraliakos, X, Aletaha, D, Iagnocco, A, Gisondi, P, Balint, PV, Bertheussen, H, Boehncke, WH, Damjanov, NS, de Wit, M, Errichetti, E, Marzo-Ortega, H, Protopopov, M, Puig, L, Queiro, R, Ruscitti, P, Savage, L, Schett, G, Siebert, S, Stamm, TA, Studenic, P, Tinazzi, I, Van den Bosch, FE, van der Helm-van Mil, A, Watad, A, Smolen, JS, McGonagle, DG. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2023; 82(9)DOI:10.1136/ard-2023-224148. PMID:37295926. IF:20.300(Q1/1D).

Sanchez-Rodriguez, G, Puig, L. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(12)DOI:10.3390/ijms241210305. PMID:37373452. IF:4.900(Q1/3D).

Ruiz-Salas, V, Podlipnik, S, Sandoval-Clavijo, A, Sanmartin-Jimenez, O, Bernia-Petit, E, Bonfill-Orti, M, Bassas-Freixas, P, Yebenes-Marsal, M, Florez-Menendez, A, Sola-Ortigosa, J, Just-Sarobe, M, Aguayo-Ortiz, RS, Niubo, EMI, Quintana-Codina, M, Deza, G, Jaka, A, Fuentes, MJ, Canueto, J, Toll, A. Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study. DERMATOLOGY. 2023; 239(5)DOI:10.1159/000530813. PMID:37257423. IF:3.000(Q2/4D).